Ultra-low biomass sequencing workflow (LBV-Seq) enables de novo metagenomic reconstruction of DNA and RNA viral genomes
Authors:
- Natalie J. Wu-WoodsNWNatalie J. Wu-Woods
- Anna E. RomanoARAnna E. Romano
- Christopher R. NeimethCNChristopher R. Neimeth
- Anika GuptaAGAnika Gupta
- Xinyue (Penny) PeiXPXinyue (Penny) Pei
- Adam C. BledsoeABAdam C. Bledsoe
- Joseph A. MurrayJMJoseph A. Murray
- Rok Seon ChoungRCRok Seon Choung
- Sonia S. KupferSKSonia S. Kupfer
- Bana JabriBJBana Jabri
- Rustem F. IsmagilovRIRustem F. Ismagilov
Preprint
Abstract
Genome-resolved virome analysis remains inaccessible for many samples, including those with clinical relevance, because viral nucleic acid recovered after enrichment is often too scarce to support de novo genome assembly. As a result, many analyses are limited to sparse read-level detection, which cannot recover divergent viruses, resolve strains, or interpret gene-level variation. Here, we developed Low Biomass Viral Sequencing (LBV-Seq), a workflow that couples low-input viral sample handling with modified primary template-directed amplification and short- or long-read sequencing to enable de novo reconstruction of DNA and RNA viral genomes from sub-femtogram to nanogram inputs. LBV-Seq reproducibly captures the same relative community composition, amplifies diverse viruses, and achieved broad genome coverage across nearly all targets regardless of viral genome structure, Baltimore class, abundance, or input mass. Short-read assemblies recovered near-complete genomes from femtogram-scale inputs. Long-read sequencing provided orthogonal support for genome structure, with PacBio HiFi reads spanning large portions of viral genomes and, in some cases, complete small viral genomes. Applied to virus-enriched human duodenal biopsy eluates, LBV-Seq provided proof-of-feasibility for recovering both bacteriophage and eukaryotic viral genomes from low-input biopsy-derived material. In the eluates tested, LBV-Seq recovered co-occurring Alphatorquevirus and Betatorquevirus genomes estimated to be present at roughly 10 copies/µL and at viral masses below 0.1 fg/µL. LBV-Seq enables genome-resolved virome analysis in samples previously limited to detection-based viromics, supporting viral discovery and strain-resolved analyses in settings where viral mass is low, including viruses enriched from human tissue biopsies.Keywords
Funding Information
- National Science Foundation (2139433)
This publication has 47 references indexed in Scilit:
- AAV yield, bioactivity, and particle heterogeneity are impacted by genome size and non-coding DNA elementsMolecular Therapy - Methods & Clinical Development, 2025
- Considerations and Opportunities for Probe Capture Enrichment Sequencing of Emerging Viruses from WastewaterEnvironmental Science & Technology, 2024
- Challenges of Studying the Human Virome – Relevant Emerging TechnologiesTrends in Microbiology, 2021
- Structure and Organization of Virus Genomes2019
- Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse ModelCell Host & Microbe, 2019
- A complete protocol for whole-genome sequencing of virus from clinical samples: Application to coronavirus OC43Virology, 2019
- Salmon provides fast and bias-aware quantification of transcript expressionNature Methods, 2017
- Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel DiseaseCell, 2015
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Letter to the editorCytometry Part A, 2003